Physician profile
Daniel Mccauley
NPI 1710088109
$1,566.51
in general payments reported to CMS, 2019-2025
21 companies · $48.57 in 2025
The $48.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $108 · 2021: $378 · 2022: $131 · 2023: $156 · 2024: $265 · 2025: $48.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $292.16 | 2019-2021 | |
| Hologic Sales and Service, LLC | $146.36 | 2020-2025 | Aptima |
| Amgen INC. | $125.00 | 2024 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.59 | 2024 | Jardiance |
| Astellas Pharma US INC | $117.59 | 2023 | Veozah |
| Therapeuticsmd, INC. | $115.10 | 2019 | |
| Nestle Healthcare Nutrition INC. | $103.79 | 2021 | |
| Janssen Pharmaceuticals, INC | $83.66 | 2019 | |
| Abbvie INC. | $74.86 | 2019-2022 | |
| Pfizer INC. | $68.99 | 2019-2021 | |
| Organon LLC | $55.90 | 2021-2023 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $52.57 | 2020 | |
| Aspira Women'S Health INC | $43.55 | 2022 | |
| Myovant Sciences INC. | $30.04 | 2022 | |
| Allergan, INC. | $27.55 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $25.62 | 2023 | |
| Amag Pharmaceuticals, INC. | $23.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2019 | |
| Agile Therapeutics, INC. | $18.04 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.78 | 2020 | |
| Merck Sharp & Dohme LLC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mccauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.